9,288 Shares in DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Acquired by MQS Management LLC

MQS Management LLC bought a new stake in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund bought 9,288 shares of the medical instruments supplier’s stock, valued at approximately $231,000.

Other hedge funds have also made changes to their positions in the company. 9258 Wealth Management LLC bought a new stake in shares of DENTSPLY SIRONA in the fourth quarter valued at about $203,000. Principal Securities Inc. purchased a new position in DENTSPLY SIRONA during the 4th quarter valued at about $26,000. Dimensional Fund Advisors LP raised its holdings in shares of DENTSPLY SIRONA by 10.3% in the 4th quarter. Dimensional Fund Advisors LP now owns 2,122,355 shares of the medical instruments supplier’s stock valued at $75,535,000 after purchasing an additional 197,431 shares in the last quarter. Norges Bank purchased a new stake in shares of DENTSPLY SIRONA in the 4th quarter worth approximately $114,207,000. Finally, PNC Financial Services Group Inc. boosted its stake in shares of DENTSPLY SIRONA by 11.0% during the fourth quarter. PNC Financial Services Group Inc. now owns 67,988 shares of the medical instruments supplier’s stock valued at $2,420,000 after purchasing an additional 6,729 shares in the last quarter. 95.70% of the stock is currently owned by hedge funds and other institutional investors.

DENTSPLY SIRONA Stock Performance

Shares of XRAY stock opened at $26.29 on Friday. The business has a fifty day moving average of $25.56 and a 200 day moving average of $27.86. DENTSPLY SIRONA Inc. has a 1 year low of $23.58 and a 1 year high of $37.60. The company has a debt-to-equity ratio of 0.57, a current ratio of 1.33 and a quick ratio of 0.87. The firm has a market capitalization of $5.46 billion, a price-to-earnings ratio of -59.75, a price-to-earnings-growth ratio of 1.25 and a beta of 1.00.

DENTSPLY SIRONA (NASDAQ:XRAY) last released its earnings results on Wednesday, July 31st. The medical instruments supplier reported $0.49 EPS for the quarter, missing analysts’ consensus estimates of $0.50 by ($0.01). DENTSPLY SIRONA had a positive return on equity of 11.86% and a negative net margin of 4.75%. The firm had revenue of $984.00 million for the quarter, compared to analyst estimates of $993.61 million. During the same period last year, the firm earned $0.51 EPS. The company’s revenue for the quarter was down 4.3% compared to the same quarter last year. As a group, research analysts expect that DENTSPLY SIRONA Inc. will post 1.99 earnings per share for the current year.

DENTSPLY SIRONA Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, October 11th. Investors of record on Friday, September 27th will be issued a dividend of $0.16 per share. The ex-dividend date of this dividend is Friday, September 27th. This represents a $0.64 annualized dividend and a dividend yield of 2.43%. DENTSPLY SIRONA’s dividend payout ratio (DPR) is presently -145.45%.

Analysts Set New Price Targets

XRAY has been the subject of a number of analyst reports. Stifel Nicolaus lowered their target price on DENTSPLY SIRONA from $30.00 to $28.00 and set a “hold” rating for the company in a report on Thursday, July 18th. Evercore ISI dropped their price objective on DENTSPLY SIRONA from $28.00 to $27.00 and set an “outperform” rating on the stock in a research report on Tuesday, July 9th. Needham & Company LLC reiterated a “buy” rating and issued a $34.00 target price on shares of DENTSPLY SIRONA in a report on Tuesday, August 20th. Robert W. Baird lowered their price target on shares of DENTSPLY SIRONA from $33.00 to $31.00 and set a “neutral” rating on the stock in a report on Monday, July 22nd. Finally, Barrington Research reiterated an “outperform” rating and set a $36.00 price objective on shares of DENTSPLY SIRONA in a research note on Friday. Five analysts have rated the stock with a hold rating and seven have given a buy rating to the company. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $33.22.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.